GATAD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.570800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.994200E-01
Normal-vs-Stage2
7.135000E-01
Normal-vs-Stage3
6.859700E-03
Normal-vs-Stage4
3.118400E-01
Stage1-vs-Stage2
9.439400E-01
Stage1-vs-Stage3
2.638000E-02
Stage1-vs-Stage4
3.862600E-01
Stage2-vs-Stage3
8.956700E-04
Stage2-vs-Stage4
3.460200E-01
Stage3-vs-Stage4
2.378200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.549200E-01
Normal-vs-AfricanAmerican
9.066200E-01
Normal-vs-Asian
7.458000E-01
Caucasian-vs-AfricanAmerican
5.485800E-01
Caucasian-vs-Asian
8.160600E-01
AfricanAmerican-vs-Asian
5.969400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.809000E-01
Normal-vs-Female
8.844400E-01
Male-vs-Female
2.224400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.207200E-01
Normal-vs-Age(41-60Yrs)
3.878600E-01
Normal-vs-Age(61-80Yrs)
9.935600E-01
Normal-vs-Age(81-100Yrs)
8.947800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.419000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.845200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.018800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.238500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.322980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.771000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.465600E-01
Normal-vs-Daily Drinker
8.661600E-01
Normal-vs-Weekly Drinker
8.474000E-01
Normal-vs-Occasional Drinker
6.354600E-01
Normal-vs-Social Drinker
3.867600E-01
Non Drinker-vs-Daily Drinker
7.760400E-01
Non Drinker-vs-Weekly Drinker
7.572200E-01
Non Drinker-vs-Occasional Drinker
4.206600E-01
Non Drinker-vs-Social Drinker
9.747500E-02
Daily Drinker-vs-Weekly Drinker
9.135400E-01
Daily Drinker-vs-Occasional Drinker
6.922000E-01
Daily Drinker-vs-Social Drinker
2.666400E-01
Weekly Drinker-vs-Occasional Drinker
8.354400E-01
Weekly Drinker-vs-Social Drinker
4.213600E-01
Occasional Drinker-vs-Social Drinker
3.906800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.067000E-01
Normal-vs-Grade 2
5.266100E-02
Normal-vs-Grade 3
7.163800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.099200E-01
Grade 1-vs-Grade 3
3.420800E-01
Grade 1-vs-Grade 4
2.067000E-01
Grade 2-vs-Grade 3
8.015900E-02
Grade 2-vs-Grade 4
5.266100E-02
Grade 3-vs-Grade 4
7.163800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.863600E-01
Normal-vs-NonDiabetic
6.558400E-01
Diabetic-vs-NonDiabetic
6.772300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.130600E-01
Normal-vs-NoPancreatitis
8.091200E-01
Pancreatitis-vs-NoPancreatitis
7.043200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.957000E-01
Normal-vs-N1
7.098400E-01
N0-vs-N1
3.681000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.579600E-01
Normal-vs-TP53-NonMutant
2.295200E-01
TP53-Mutant-vs-TP53-NonMutant
9.075800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
